Beyondspring Rg

BeyondSpring Inc. is a clinical‑stage biopharma focused on the Phase III‑ready Plinabulin platform that treats NSCLC and prevents chemotherapy‑induced neutropenia, with active combination trials and a robust drug discovery pipeline.

Headquarters: China (CHN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 40
HQ: Florham Park

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
BYSI	Beyondspring Rg Cap: 0.1B	EQUITY	NMS	USD	KYG108301006	Active	📈